Market Research

Polycystic Ovarian Syndrome Treatment Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope

Polycystic ovarian syndrome is a disorder in which hormones are out of control for females and they have male hormones that are higher than normal, which causes them to skip menstrual periods and makes pregnancy more difficult for them.

Sizing and Forecast

The polycystic ovarian syndrome treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2023 to $4.74 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%.  The  growth in the historic period can be attributed to increased awareness, advances in medical technology, lifestyle changes, pharmaceutical innovations, government initiatives.

The polycystic ovarian syndrome treatment market size is expected to see strong growth in the next few years. It will grow to $6.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.9%.  The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote monitoring, research and development, rising prevalence, supportive regulatory environment. Major trends in the forecast period include holistic approach, patient-centered care, digital health solutions, multidisciplinary care, patient education.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Segmentation & Regional Insights

The polycystic ovarian syndrome treatment market covered in this report is segmented –

1) By Drug Type: Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors

2) By Surgery Type: Ovarian Wedge Resection, Laparoscopic Ovarian Drilling

3) By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Gynecology Centers, Feminist Health Centers

North America was the largest region in the polycystic ovarian syndrome treatment market in 2023. Western Europe was the second largest region in the polycystic ovarian syndrome treatment market. The regions covered in the polycystic ovarian syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2827&type=smp

Major Driver Impacting Market Growth

The global rise in genetic and hormonal disorders is a key factor driving the growth of the polycystic ovarian syndrome (PCOS) treatment market. PCOS is a prevalent hormonal disorder among premenopausal women worldwide, with reproductive, endocrine, and metabolic abnormalities. The PCOS prevalence ranges from 2.2% to 26% globally and is highly variable. In China, the figures range between 2% to 7.5% and 6.3% in Sri Lanka, 9.13% in south India and 22.5% in Maharashtra. The rise in genetic and hormonal disorders globally is expected to increase the growth of the polycystic ovarian syndrome treatment market.

Key Industry Players

Major companies operating in the polycystic ovarian syndrome treatment market include Bristol-Myer Squibb Co, Bayer AG, Pfizer Inc., Merck KGaA, Sanofi SA, AstraZeneca PLC, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott Laboratories, Addex Therapeutics Ltd., BIOCAD, Allergan plc., Johnson and Johnson, Ferring Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Organon & Co, Forendo Pharma Ltd., GlaxoSmithKline plc, AbbVie Inc., Eli Lilly and Company, Mylan NV, Lupin Pharmaceuticals Inc., HRA Pharma SAS, CooperSurgical Inc., TherapeuticsMD Inc., Agile Therapeutics Inc., OvaScience Inc., Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited, Glenmark Pharmaceuticals Limited

The polycystic ovarian syndrome treatment market report table of contents includes:

 

  1. Executive Summary
  2. Polycystic Ovarian Syndrome Treatment Market Characteristics
  3. Polycystic Ovarian Syndrome Treatment Market Trends And Strategies
  4. Polycystic Ovarian Syndrome Treatment Market – Macro Economic Scenario
  5. Global Polycystic Ovarian Syndrome Treatment Market Size and Growth

.

.

.

  1. Global Polycystic Ovarian Syndrome Treatment Market Competitive Benchmarking
  2. Global Polycystic Ovarian Syndrome Treatment Market Competitive Dashboard
  3. Key Mergers And Acquisitions In The Polycystic Ovarian Syndrome Treatment Market
  4. Polycystic Ovarian Syndrome Treatment Market Future Outlook and Potential Analysis
  5. Appendix

Top Major Players:

  • Bristol-Myer Squibb Co
  • Bayer AG
  • Pfizer Inc
  • Merck KgaA
  • Sanofi SA

Explore the trending research reports from TBRC:

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info  

Facebook: https://www.facebook.com/TheBusinessResearchCompany  

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  

Blog: https://blog.tbrc.info/  

Healthcare Blog: https://healthcareresearchreports.com/  

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model   

Good PR News

Recent Posts

Hazelnut Market Outlook 2024-2033: Trends and Projections

Market Size - The hazelnut market size has grown strongly in recent years. It will…

6 hours ago

IoT Gateway Devices Market Expansion 2024-2033: Growth Drivers and Dynamics

Market Size - The IoT gateway devices market size has grown rapidly in recent years.…

6 hours ago

Zinc Rich Coating Market Outlook 2024-2033: Trends and Projections

Market Size - The zinc rich coating market size has grown rapidly in recent years.…

6 hours ago

Time-Sensitive Networking (TSN) Market Outlook 2024-2033: Trends and Projections

Market Size - The time-sensitive networking (TSN) market size has grown exponentially in recent years.…

6 hours ago